Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

429 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

NCT02224456

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Nanjing, Jiangsu, China
View all 19 locations
View Trial Details
Completed

Safety and Acceptability of a Vaginal Microbicide

NCT00111943

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +24 more
Locations
  • Alabama Microbicide CRS Birmingham, Alabama, United States
  • Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS) The Bronx, New York, United States
  • NARI Arogya Aadhar Clinic CRS Pune, Maharashtra, India
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

NCT03180619

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Coalition of Inclusive Medicine Los Angeles, California, United States
  • Silicon Valley Research Institute, Inc San Jose, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Harborview Medical Center Seattle, Washington, United States
View all 30 locations
View Trial Details
Completed

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

NCT04248426

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Altasciences Montreal, Quebec, Canada
  • Republican Clinical Hospital "Timofei Mosneaga" Arensia EM Unit Chisinau, Republic of Moldova, Moldova
  • Medical Center of Limited Liability Company "Harmoniya krasy" Department of Clinical Trials Kyiv, Ukraine
View Trial Details
Completed

A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed

NCT03463369

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • ZiekenhuisNetwerk Antwerpen (ZNA) - Stuivenberg Antwerp, Belgium
  • Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universite Libre de Bruxelles (ULB) - Hopital Erasme Brussels, Belgium
  • Ruprecht-Karls-U Mannheim Mannheim, Baden-Wurttemberg, Germany
View all 14 locations
View Trial Details

Related conditions